Biopharmaceutical challenges associated with drugs with low aqueous solubility - The potential impact of lipid-based formulations

被引:223
作者
O'Driscoll, C. M. [1 ]
Griffin, B. T. [1 ]
机构
[1] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland
关键词
lipid-based formulations; bioactive excipients; solubility; in vitro-in vivo correlations;
D O I
10.1016/j.addr.2007.10.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The percentage of new chemical entities synthesised with low aqueous solubility and high therapeutic efficacy is growing, this presents major challenges for the drug delivery scientists. The role of physicochemical properties in identification of suitable drug candidates for oral lipid-based delivery systems is discussed. A knowledge of the interplay of physicochemical and biopharmaceutical drug properties with the physiological environment of the gastro-intestinal tract (GIT), as a prerequisite to successful formulation design, is reviewed. The importance of excipient selection with an emphasis on bioactive excipients is stressed. The need for more examples of in vitro-in Vivo Correlations as a means of maximizing the development potential and commercial future for lipid-based formulations, and, promoting confidence within the industry for these delivery systems is highlighted. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:617 / 624
页数:8
相关论文
共 39 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]   Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model [J].
Cao, Xianhua ;
Gibbs, Seth T. ;
Fang, Lanyan ;
Miller, Heather A. ;
Landowski, Christopher P. ;
Shin, Ho-Chul ;
Lennernas, Hans ;
Zhong, Yanqiang ;
Amidon, Gordon L. ;
Yu, Lawrence X. ;
Sun, Duxin .
PHARMACEUTICAL RESEARCH, 2006, 23 (08) :1675-1686
[3]  
Charman WN, 2000, J PHARM SCI-US, V89, P967, DOI 10.1002/1520-6017(200008)89:8<967::AID-JPS1>3.0.CO
[4]  
2-R
[5]   Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans [J].
Chiou, WL ;
Jeong, HY ;
Chung, SM ;
Wu, TC .
PHARMACEUTICAL RESEARCH, 2000, 17 (02) :135-140
[6]   Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs:: In vitro/in vivo case studies [J].
Constantinides, Panayiotis P. ;
Wasan, Kishor M. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (02) :235-248
[7]   Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs [J].
Cuine, Jean F. ;
Charman, William N. ;
Pouton, Colin W. ;
Edwards, Glenn A. ;
Porter, Christopher J. H. .
PHARMACEUTICAL RESEARCH, 2007, 24 (04) :748-757
[8]   Gastrointestinal transit of dosage forms in the pig [J].
Davis, SS ;
Illum, L ;
Hinchcliffe, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (01) :33-39
[9]   Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms [J].
Dressman, JB ;
Amidon, GL ;
Reppas, C ;
Shah, VP .
PHARMACEUTICAL RESEARCH, 1998, 15 (01) :11-22
[10]   Drug, meal and formulation interactions influencing drug absorption after oral administration - Clinical implications [J].
Fleisher, D ;
Li, C ;
Zhou, Y ;
Pao, LH ;
Karim, A .
CLINICAL PHARMACOKINETICS, 1999, 36 (03) :233-254